Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. 
        		 
                    		   Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E, Bartels U, Zuccaro J, Agnihotri S, Ryall S, Barszczyk M, Chornenkyy Y, Bourgey M, Bourque G, Montpetit A, Cordero F, Castelo-Branco P, Mangerel J, Tabori U, Ho KC, Huang A, Taylor KR, Mackay A, Bendel AE, Nazarian J, Fangusaro JR, Karajannis MA, Zagzag D, Foreman NK, Donson A, Hegert JV, Smith A, Chan J, Lafay-Cousin L, Dunn S, Hukin J, Dunham C, Scheinemann K, Michaud J, Zelcer S, Ramsay D, Cain J, Brennan C, Souweidane MM, Jones C, Allis CD, Brudno M, Becher O, Hawkins C. 
        		              
                         Nat Genet 
                         46 :
                    		 2014 
                    		 451-456 
                        
                       
                    		   377 
        	              
                   
                     
                       
                         ATRX mutations and glioblastoma: Impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability. 
        		 
                    		   Koschmann C, Lowenstein PR, Castro MG. 
        		              
                         Mol Cell Oncol 
                         3 :
                    		 2016 
                    		 e1167158 
                        
                       
                    		   32 
        	              
                   
                     
                       
                         Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma. 
        		 
                    		   Koschmann C, Zamler D, MacKay A, Robinson D, Wu YM, Doherty R, Marini B, Tran D, Garton H, Muraszko K, Robertson P, Leonard M, Zhao L, Bixby D, Peterson L, Camelo-Piragua S, Jones C, Mody R, Lowenstein PR, Castro MG. 
        		              
                         Oncotarget 
                         7 :
                    		 2016 
                    		 65696-65706 
                        
                       
                    		   42 
        	              
                   
                     
                       
                         Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. 
        		 
                    		   Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Sunol M, de Torres C, Cruz O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A, Jones C. 
        		              
                         Cancer Cell 
                         32 :
                    		 2017 
                    		 520-537.e5 
                        
                       
                    		   541 
        	              
                   
                     
                       
                         Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. 
        		 
                    		   Vinci M, Burford A, Molinari V, Kessler K, Popov S, Clarke M, Taylor KR, Pemberton HN, Lord CJ, Gutteridge A, Forshew T, Carvalho D, Marshall LV, Qin EY, Ingram WJ, Moore AS, Ng HK, Trabelsi S, H'mida-Ben Brahim D, Entz-Werle N, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Sunol M, Mora J, de Torres C, Cruz O, Carcaboso AM, Monje M, Mackay A, Jones C. 
        		              
                         Nat Med 
                         24 :
                    		 2018 
                    		 1204-1215 
                        
                       
                    		   97 
        	              
                   
                     
                       
                         ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization. 
        		 
                    		   Qin T, Mullan B, Ravindran R, Messinger D, Siada R, Cummings JR, Harris M, Muruganand A, Pyaram K, Miklja Z, Reiber M, Garcia T, Tran D, Danussi C, Brosnan-Cashman J, Pratt D, Zhao X, Rehemtulla A, Sartor MA, Venneti S, Meeker AK, Huse JT, Morgan MA, Lowenstein PR, Castro MG, Yadav VN, Koschmann C. 
        		              
                         Cell Rep 
                         38 :
                    		 2022 
                    		 110216 
                        
                       
                    		   26 
        	              
                   
                     
                       
                         Splicing is an alternate oncogenic pathway activation mechanism in glioma. 
        		 
                    		   Siddaway R, Milos S, Vadivel AKA, Dobson THW, Swaminathan J, Ryall S, Pajovic S, Patel PG, Nazarian J, Becher O, Brudno M, Ramani A, Gopalakrishnan V, Hawkins C. 
        		              
                         Nat Commun 
                         13 :
                    		 2022 
                    		 588 
                        
                       
                    		   19 
        	              
                   
                     
                       
                         Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma. 
        		 
                    		   Messinger D, Harris MK, Cummings JR, Thomas C, Yang T, Sweha SR, Woo R, Siddaway R, Burkert M, Stallard S, Qin T, Mullan B, Siada R, Ravindran R, Niculcea M, Dowling AR, Bradin J, Ginn KF, Gener MAH, Dorris K, Vitanza NA, Schmidt SV, Spitzer J, Li J, Filbin MG, Cao X, Castro MG, Lowenstein PR, Mody R, Chinnaiyan A, Desprez PY, McAllister S, Dun MD, Hawkins C, Waszak SM, Venneti S, Koschmann C, Yadav VN. 
        		              
                         Neuro Oncol 
                         25 :
                    		 2023 
                    		 54-67 
                        
                       
                    		   5 
        	              
                   
                     
                       
                         Structural variants shape driver combinations and outcomes in pediatric high-grade glioma. 
        		 
                    		   Dubois FPB, Shapira O, Greenwald NF, Zack T, Wala J, Tsai JW, Crane A, Baguette A, Hadjadj D, Harutyunyan AS, Kumar KH, Blattner-Johnson M, Vogelzang J, Sousa C, Kang KS, Sinai C, Wang DK, Khadka P, Lewis K, Nguyen L, Malkin H, Ho P, O'Rourke R, Zhang S, Gold R, Deng D, Serrano J, Snuderl M, Jones C, Wright KD, Chi SN, Grill J, Kleinman CL, Goumnerova LC, Jabado N, Jones DTW, Kieran MW, Ligon KL, Beroukhim R, Bandopadhayay P. 
        		              
                         Nat Cancer 
                         3 :
                    		 2022 
                    		 994-1011 
                        
                       
                    		   18 
        	              
                   
                     
                       
                         Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors. 
        		 
                    		   Giacomini G, Piquet S, Chevallier O, Dabin J, Bai SK, Kim B, Siddaway R, Raught B, Coyaud E, Shan CM, Reid RJD, Toda T, Rothstein R, Barra V, Wilhelm T, Hamadat S, Bertin C, Crane A, Dubois F, Forne I, Imhof A, Bandopadhayay P, Beroukhim R, Naim V, Jia S, Hawkins C, Rondinelli B, Polo SE. 
        		              
                         Nucleic Acids Res 
                         52 :
                    		 2024 
                    		 2372-2388 
                        
                       
                    		   0 
        	              
                   
                     
                       
                         Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment. 
        		 
                    		   Levine AB, Nobre L, Das A, Milos S, Bianchi V, Johnson M, Fernandez NR, Stengs L, Ryall S, Ku M, Rana M, Laxer B, Sheth J, Sbergio SG, Fedoráková I, Ramaswamy V, Bennett J, Siddaway R, Tabori U, Hawkins C. 
        		              
                         Nat Commun 
                         15 :
                    		 2024 
                    		 5790 
                        
                       
                    		   0